105 related articles for article (PubMed ID: 13678472)
1. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA.
Anderson J; Banerjea A; Planelles V; Akkina R
AIDS Res Hum Retroviruses; 2003 Aug; 19(8):699-706. PubMed ID: 13678472
[TBL] [Abstract][Full Text] [Related]
2. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
Anderson J; Banerjea A; Akkina R
Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.
Anderson J; Akkina R
AIDS Res Ther; 2005 Jan; 2(1):1. PubMed ID: 15813990
[TBL] [Abstract][Full Text] [Related]
5. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA
AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411
[TBL] [Abstract][Full Text] [Related]
6. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
Anderson J; Akkina R
Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of CXCR4 expression by SDF-KDEL in CD34(+) hematopoietic stem cells: An anti-human immunodeficiency virus strategy.
Zhang JC; Sun L; Nie QH; Huang CX; Jia ZS; Wang JP; Lian JQ; Li XH; Wang PZ; Zhang Y; Zhuang Y; Sun YT; Bai X
J Virol Methods; 2009 Oct; 161(1):30-7. PubMed ID: 19463855
[TBL] [Abstract][Full Text] [Related]
8. Stable gene transfer of CCR5 and CXCR4 siRNAs by sleeping beauty transposon system to confer HIV-1 resistance.
Tamhane M; Akkina R
AIDS Res Ther; 2008 Jul; 5():16. PubMed ID: 18667075
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of CXCR4 expression in MT4 cells by a recombinant vector expressing antisense RNA to CXCR4 and its potential anti-HIV-1 effect.
Xing HC; Xu XY; Liu Z; Wang QH; Yu M; Si CW
Jpn J Infect Dis; 2004 Jun; 57(3):91-6. PubMed ID: 15218216
[TBL] [Abstract][Full Text] [Related]
10. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
11. Silencing of HIV-1 gene expression by siRNAs in transduced cells.
Hayafune M; Miyano-Kurosaki N; Takaku H; Park WS
Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):795-9. PubMed ID: 16898417
[TBL] [Abstract][Full Text] [Related]
12. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
[TBL] [Abstract][Full Text] [Related]
13. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
Egorova AA; Maretina MA; Kiselev AV
Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
[TBL] [Abstract][Full Text] [Related]
14. Development of a cell-based enzyme-linked immunosorbent assay for high-throughput screening of HIV type 1 entry inhibitors targeting the coreceptor CXCR4.
Zhao Q; Lu H; Schols D; De Clercq E; Jiang S
AIDS Res Hum Retroviruses; 2003 Nov; 19(11):947-55. PubMed ID: 14678601
[TBL] [Abstract][Full Text] [Related]
15. Silencing of HIV-1 gene expression by two types of siRNA expression systems.
Hayafune M; Miyano-Kurosaki N; Park WS; Moori Y; Takaku H
Antivir Chem Chemother; 2006; 17(5):241-9. PubMed ID: 17176628
[TBL] [Abstract][Full Text] [Related]
16. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
[TBL] [Abstract][Full Text] [Related]
18. Alcohol enhances HIV type 1 infection in normal human oral keratinocytes by up-regulating cell-surface CXCR4 coreceptor.
Chen H; Zha J; Gowans RE; Camargo P; Nishitani J; McQuirter JL; Cole SW; Zack JA; Liu X
AIDS Res Hum Retroviruses; 2004 May; 20(5):513-9. PubMed ID: 15186526
[TBL] [Abstract][Full Text] [Related]
19. Cyclic zinc-dithiocarbamate-S,S'-dioxide blocks CXCR4-mediated HIV-1 infection.
Takamune N; Misumi S; Shoji S
Biochem Biophys Res Commun; 2000 Jun; 272(2):351-6. PubMed ID: 10833417
[TBL] [Abstract][Full Text] [Related]
20. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
Bai J; Rossi J; Akkina R
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
